Emerging drugs to treat obsessive-compulsive disorder
Obsessive-compulsive disorder (OCD) is a chronic and disabling neuropsychiatric disorder with a lifetime prevalence of approximately 1 – 2% and a rate of treatment resistance of 40%. Other disorders have been related to OCD and have been grouped together in a separate DSM-5 chapter, hypothesizing the existence of an ‘OC spectrum’, showing a paradigm shift in the conceptualization of the disorder.
